Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
25%
ALSO IN CANC
CANC
56
HOLDINGS
21%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 7.5% | 4.3% | 4.3% |
|
ELI LILLY & CO | 4.1% | 4.5% | 4.1% |
|
MERCK & CO. INC. | 8.3% | 3.9% | 3.9% |
|
JOHNSON & JOHNSON | 7.8% | 2.5% | 2.5% |
|
AMGEN INC | 3.8% | 2.5% | 2.5% |
FTXH Overweight Relative to CANC
|
PFIZER INC | 6.3% |
|
JOHNSON & JOHNSON | 5.2% |
|
MERCK & CO. INC. | 4.4% |
|
CARDINAL HEALTH INC | 4.4% |
|
BIOGEN IDEC INC | 4.3% |
|
VIATRIS, INC. | 4.0% |
|
ABBVIE INC | 3.7% |
|
VERTEX PHARMACEUTICALS INC | 3.5% |
|
BRISTOL-MYERS SQUIBB CO | 3.2% |
|
UNITED THERAPEUTICS CORP | 3.1% |
FTXH Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.2% |
 |
NOVARTIS AG | -4.6% |
 |
ASTRAZENECA PLC | -4.4% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
BRIDGEBIO PHARMA, INC. | -4.0% |
 |
GENMAB A/S SPONSORED ADR | -3.4% |
|
NUVALENT, INC. CLASS A | -3.3% |
|
COGENT BIOSCIENCES INC | -3.2% |
|
IMMUNOME, INC. | -2.9% |
|
CELCUITY INC. | -2.4% |